Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
06/1997
06/19/1997CA2240115A1 Antagonists of gonadotropin releasing hormone
06/19/1997CA2240111A1 Antagonists of gonadotropin releasing hormone
06/19/1997CA2240108A1 Antagonists of gonadotropin releasing hormone
06/19/1997CA2240048A1 Antagonists of gonadotropin releasing hormone
06/19/1997CA2240024A1 Nuclear receptor ligands and ligand binding domains
06/18/1997CN1152304A Substituted benzamidines, their production and their use as medicaments
06/17/1997US5639275 Capsule containing genetically engineered cells
06/11/1997EP0778277A1 Substituted heterocyclic derivatives as CRF antagonists
06/11/1997EP0700395B1 Indole derivatives as steroid 5-alpha-reductase inhibitors
06/11/1997EP0656786A4 Health supplements containing phyto-oestrogens, analogues or metabolites thereof.
06/10/1997US5637605 α-fluoro-α-1-(1,2,4-triazolyl)-phenylmethyl derivatives useful as aromatase inhibitors
06/10/1997US5637568 Composition for the sustained and controlled release of medicamentous substances and a process for preparing the same
06/05/1997WO1997019953A2 New lh-rh antagonists with improved effectiveness
06/05/1997WO1997019947A1 2'-[[4'-HALO-[1,1'-BIPHENYL]-4-YL]METHYL]-5'-METHYL-SPIRO[CYCLOPENTANE-1,7'(8'H)-[3H]IMIDAZO[2,1-b]PURIN]-4'(5'H)-ONES
06/05/1997WO1997019918A1 Novel 2,3,5-trimethyl-4-hydroxy anilide derivatives, preparation thereof and therapeutical use thereof
06/05/1997WO1997019914A1 Amino acid derivatives, medicaments containing said compounds and methods of producing said compounds
06/05/1997WO1997019913A1 Amino acid derivatives, medicaments containing said compounds and methods of producing them
06/05/1997WO1997019683A1 Hydrolysis-optimized lipid emulsions and use thereof
06/05/1997WO1997014712A3 Sulphamate derivatives of 1,3,5(10)-estratriene derivatives, methods of producing them and pharmaceutical compounds containing them
06/05/1997DE19648566A1 Isotonic lipid emulsion for parenteral application for nourishment,
06/05/1997DE19544686A1 Aminosäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Amino acid derivatives, medicaments containing these compounds and processes for their preparation
06/05/1997DE19544685A1 Aminosäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Amino acid derivatives, medicaments containing these compounds and processes for their preparation
06/05/1997DE19544212A1 Neue LH-RH-Antagonisten mit verbesserter Wirkung New LH-RH antagonists with improved activity
06/05/1997CA2238570A1 New lh-rh antagonists with improved effectiveness
06/05/1997CA2237956A1 2'-[[4'-halo-[1,1'-biphenyl]-4-yl]methyl]-5'-methyl-spiro[cyclopentane-1,7'(8'h)-[3h]imidazo[2,1-b]purin]-4'(5'h)-ones
06/05/1997CA2235937A1 Amino acid derivatives, medicaments containing said compounds and methods of producing them
06/04/1997EP0559690B1 8-ENE-19, 11 beta-BRIDGED STEROIDS, THEIR PREPARATION AND PHARMACEUTICAL FORMULATIONS CONTAINING THEM
06/04/1997CN1035055C Process for preparaing unsaturated 17-'beta' substituted 3-carboxysteroids
06/03/1997US5635502 Mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ACE
05/1997
05/29/1997WO1997018833A1 Methods of increasing lean tissue mass using ob protein compositions
05/29/1997WO1997018808A1 4-hydroxycoumarin-3-carboxamides for the treatment of diabetes mellitus
05/29/1997CA2358862A1 Methods of increasing lean tissue mass using ob protein compositions
05/29/1997CA2236163A1 Methods of increasing lean tissue mass using ob protein compositions
05/28/1997EP0775339A1 Current-to-pressure transducer with selectable, adjustable input filter
05/28/1997EP0775156A1 Pharmaceutical compositions containing estra-1,3,5(10)-triene derivatives
05/28/1997EP0775155A1 Estra-1,3,5(10)-triene derivatives, methods of preparing such compounds and pharmaceutical compositions containing them
05/28/1997EP0775120A1 Novel pyrimidine derivatives and processes for the preparation thereof
05/28/1997CN1150803A Pyrazolo and pyrrolopyridines
05/28/1997CN1150802A Benzoylecgonine, ecgonine and ecgonidine derivatives
05/28/1997CN1150799A Benzoheterocyclic derivatives
05/27/1997US5633241 Administering as antileukemia agent
05/22/1997WO1997018184A1 Fluorinated propranolol and related methods
05/22/1997WO1997017951A1 Stabilized thyroid hormone preparations and methods of making same
05/22/1997WO1997017937A2 Gene-therapeutic nucleic acid construct, production of same and use of same in the treatment of heart disorders
05/22/1997CA2235707A1 Stabilized thyroid hormone preparations and methods of making same
05/21/1997CN1150428A Corticotropin releasing factor antagonists
05/15/1997WO1997017316A1 4-phenyl-4-oxo-2-butenoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity
05/15/1997WO1997016983A1 Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
05/13/1997US5629425 Haloalkyl hemisolvates of 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-piperidinoethoxy)-benzoyl]benzo[b]thiophene
05/13/1997US5629315 Treatment of psoriasis, asthma,osteoporosis, alcoholic hepatitis, and premature labor
05/09/1997WO1997016549A2 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands
05/09/1997WO1997016434A1 (-) cis-6(s)-phenyl-5(r)[4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol d-tartrate
05/09/1997WO1997016185A2 A pharmaceutical composition for the treatment of autoimmune diseases
05/09/1997WO1997016184A1 Method and pharmaceutical composition for regulating lipid concentration
05/09/1997WO1997016178A1 Stabilised pharmaceutical preparations containing thyroid hormone
05/09/1997CA2236297A1 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands
05/07/1997CN1149252A Novel substituted tryptamines, phenalkylamines and related compounds
05/02/1997EP0770059A1 Substituted benzamidines, their production and their use as medicaments
05/02/1997EP0769960A1 Pharmaceutical compositions containing a bile salt and a buffer for increased bioavailability of an active compound
05/02/1997EP0769956A1 Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
05/01/1997WO1997015671A1 Luminal cholecystokinin-releasing factor
05/01/1997WO1997015574A1 Polymorphic forms of a growth hormone secretagogue
05/01/1997WO1997015564A1 4-oxa and 4-thia steroids
05/01/1997WO1997015558A1 17-alkyl-7-substituted-4-aza steroid derivatives
05/01/1997WO1997015556A1 3-spiro-indolin-2-one derivatives as vasopressin and/or oxytocin receptor ligands
05/01/1997WO1997015550A1 Fluoro-substituted benzoylpropionic acid derivatives
05/01/1997WO1997015302A1 Pharmaceutical compositions of levo-enantiomers of medetomidine derivatives and their use
05/01/1997CA2238940A1 Luminal cholecystokinin-releasing factor
05/01/1997CA2233966A1 4-oxa and 4-thia steroids
05/01/1997CA2233862A1 17-alkyl-7-substituted-4-aza steroid derivatives
05/01/1997CA2233075A1 Fluoro-substituted benzoylpropionic acid derivatives
05/01/1997CA2232336A1 Pharmaceutical compositions of levo-enantiomers of medetomidine derivatives and their use
04/1997
04/30/1997DE19541128A1 Stabilisierte schilddrüsenhormonhaltige Arzneimittel Stabilized thyroid hormone-containing drugs
04/29/1997US5624935 Antidiabetic agents, hypoglycemic agents or antilipemic agents
04/24/1997WO1997014712A2 Sulphamate derivatives of 1,3,5(10)-estratriene derivatives, methods of producing them and pharmaceutical compounds containing them
04/24/1997WO1997014670A1 Lignans, a process for their production and pharmaceutical compositions and uses thereof
04/24/1997WO1997014429A1 Stable pharmaceutical forms of administration containing parathormone
04/24/1997WO1997014418A1 16-substituted-6-aza-steroid 5-alpha-reductase inhibitors
04/24/1997DE19540233A1 Sulfamat-Derivate von 1,3,5(10)-Estratrien-Derivaten, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen Containing sulphamate derivatives of 1,3,5 (10) -estratrien-derivatives, processes for their preparation and pharmaceutical compositions comprising these compounds
04/24/1997DE19538687A1 Stabile pharmazeutische Darreichungsformen enthaltend Parathormon The stable pharmaceutical dosage forms containing parathyroid hormone
04/24/1997CA2234724A1 Stable pharmaceutical forms of administration containing parathyroid hormone
04/24/1997CA2233084A1 16-substituted-6-aza-steroid 5-.alpha.-reductase inhibitors
04/23/1997EP0769022A1 O-glycosylated authentic igf-i and truncated variants thereof, a method of preparation thereof and pharmaceutical compositions
04/23/1997EP0600873B1 Therapeutically effective topical application of st1435
04/22/1997US5622962 Prostate cancer, skin disorders, baldness
04/22/1997US5622961 5α-reductase inhibitors
04/22/1997US5622721 Dosage forms of risedronate
04/17/1997WO1997013511A1 Methods of inhibiting plasminogen activator inhibitor 1
04/17/1997CA2234404A1 Methods of inhibiting plasminogen activator inhibitor 1
04/16/1997EP0767801A1 Endothelin antagonists ii
04/16/1997EP0536282B1 Meducament for treating prostatic adenocarcinoma
04/16/1997CN1147520A 11-(substituted phenyl)-estra-4,9-diene derivatives
04/15/1997US5621102 Reacting pinanediol chiral director and haloalkyl dialkoxy metalloid compound to undergo homologation reaction to form intermediate, reacting it with grignard reagent to form secondary alchol, acylating, coupling side chain
04/15/1997US5620988 Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents
04/15/1997US5620984 Enatiomerically pure hydroxylated xanthine compounds to treat inflammatory diseases
04/10/1997WO1997012878A1 Amino acid derivatives, the preparation and use thereof as endothelin antagonists
04/10/1997WO1997012853A1 Dimer-selective rxr modulators and methods for their use
04/10/1997DE19536891A1 Neue Aminosäurederivate, ihre Herstellung und Verwendung New amino acid derivatives, their preparation and use
04/10/1997CA2233888A1 Dimer-selective rxr modulators and methods for their use
04/10/1997CA2231500A1 Novel amino acid derivatives, their preparation and use